Effects of systemic injections of Vilazodone, a selective serotonin reuptake inhibitor and serotonin 1 A receptor agonist, on anxiety induced by predator stress in rats

European Journal of Pharmacology

Volumn 504, Issue 1-2, 2004, Pages 65-77

  Adamec, Robert ^a   Bartoszyk, Gerd D ^b   Burton, Paul ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b MERCK KGAA   (Germany)

Author keywords

5 HT1 A; Anxiety; Predator stress; SSRI; Vilazodone

Indexed keywords

SEROTONIN 1A AGONIST; SEROTONIN UPTAKE INHIBITOR; VILAZODONE;

ALERTNESS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EMOTIONAL STRESS; MALE; MAZE TEST; NONHUMAN; PREDATOR; PRIORITY JOURNAL; PROPHYLAXIS; STARTLE REFLEX;

ANIMALS; ANXIETY; BENZOFURANS; CATS; INDOLES; INJECTIONS, INTRAPERITONEAL; MALE; PIPERAZINES; PREDATORY BEHAVIOR; RATS; RATS, LONG-EVANS; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN AGONISTS; SEROTONIN UPTAKE INHIBITORS; STARTLE REACTION; STRESS;

EID: 6944238722     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.09.009     Document Type: Article

References (37)

1. R. Adamec Transmitter systems involved in neural plasticity underlying increased anxiety and defenseâ€"implications for understanding anxiety following traumatic stress Neurosci. Biobehav. Rev. 21 1997 755 765
2. R. Adamec Report of an Initial Test of EMD in a Predator Stress Model of Post Traumatic Stress Disorder vol. 1 2000 Merck Germany 1 22
3. R. Adamec Does long term potentiation in periaqueductal gray (PAG) mediate lasting changes in rodent ALB produced by predator stress? Effects of low frequency stimulation (LFS) of PAG on place preference and changes in ALB produced by predator stress Behav. Brain Res. 120 2001 111 135
4. R.E. Adamec, and T. Shallow Lasting effects on rodent anxiety of a single exposure to a cat Physiol. Behav. 54 1993 101 109
5. R.E. Adamec, U. Sayin, and A. Brown The effects of corticotrophin releasing factor (CRF) and handling stress on behavior in the elevated plus-maze test of anxiety J. Psychopharmacol. 5 1991 175 186
6. R.E. Adamec, T. Shallow, and J. Budgell Blockade of CCK(B) but not CCK(A) receptors before and after the stress of predator exposure prevents lasting increases in anxiety-like behavior: implications for anxiety associated with posttraumatic stress disorder Behav. Neurosci. 111 1997 435 449
7. R. Adamec, P. Kent, H. Anisman, T. Shallow, and Z. Merali Neural plasticity, neuropeptides and anxiety in animalsâ€"implications for understanding and treating affective disorder following traumatic stress in humans Neurosci. Biobehav. Rev. 23 1998 301 318
8. R.E. Adamec, P. Burton, T. Shallow, and J. Budgell NMDA receptors mediate lasting increases in anxiety-like behavior produced by the stress of predator exposureâ€"implications for anxiety associated with posttraumatic stress disorder Physiol. Behav. 65 1999 723 737
9. R.E. Adamec, P. Burton, T. Shallow, and J. Budgell Unilateral block of NMDA receptors in the amygdala prevents predator stress-induced lasting increases in anxiety-like behavior and unconditioned startleâ€" effect on behavior depends on the hemisphere Physiol. Behav. 65 1999 739 751
10. R. Adamec, J. Blundell, and A. Collins Neural plasticity and stress induced changes in defense in the rat Neurosci. Biobehav. Rev. 25 2001 721 744
11. R. Adamec, J. Blundell, and P. Burton Phosphorylated cyclic AMP response element binding protein expression induced in the periaqueductal gray by predator stress: its relationship to the stress experience, behavior and limbic neural plasticity Prog. Neuro-Psychopharmacol. Biol. Psychiatry 27 8 2003 1243 1267
12. G. Bagdy, M. Graf, Z.E. Anheuer, E.A. Modos, and S. Kantor Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist Way-100635 Int. J. Neuropsychopharmacol. 4 4 2001 399 408
13. G.D. Bartoszyk, R. Hegenbart, and H. Ziegler EMD 68843, a serotonin reuptake inhibitor with selective presynaptic 5-HT1A receptor agonistic properties Eur. J. Pharmacol. 322 1997 147 153
14. R.J. Blanchard, and D.C. Blanchard Antipredator defensive behaviors in a visible burrow system J. Comp. Psychol. 103 1989 70 82
15. D.C. Blanchard, R.J. Blanchard, A. De Padua Carobrez, R. Veniegas, R.J. Rodgers, and J.K. Shepherd MK-801 produces a reduction in anxiety-related antipredator defensiveness in male and female rats and a gender-dependent increase in locomotor behavior Psychopharmacology 108 1992 352 362
16. H. Cohen, S. Friedberg, M. Michael, M. Kotler, and K. Zeev Interaction of CCK-4 induced anxiety and post-cat exposure anxiety in rats Depress. Anxiety 4 1996 144 145
17. H. Cohen, Z. Kaplan, and M. Kotler CCK-antagonists in a rat exposed to acute stress: implication for anxiety associated with post-traumatic stress disorder Depress. Anxiety 10 1999 8 17
18. H. Cohen, J. Benjamin, Z. Kaplan, and M. Kotler Administration of high-dose ketoconazole, an inhibitor of steroid synthesis, prevents posttraumatic anxiety in an animal model Eur. Neuropsychopharmacol. 10 2000 429 435
19. H. Cohen, J. Zohar, and M. Matar The relevance of differential response to trauma in an animal model of posttraumatic stress disorder Biol. Psychiatry 53 2003 463 473
20. R. DeJongh, L. Groenink, J. van der Gugten, and B. Olivier The light-enhanced startle paradigm as a putative animal model for anxiety: effects of chlordiazepoxide, flesinoxan and fluvoxamine Psychopharmacology 159 2 2002 176 180
21. 1A-receptor ligands in dorsal raphe and ventral hippocampus Pharmacol. Biochem. Behav. 54 1996 123 128
22. S.E. File, and A.G. Wardill The reliability of the hole-board apparatus Psychopharmacologia 44 1975 47 51
23. S.E. File, and A.G. Wardill Validity of head-dipping as a measure of exploration in a modified hole-board Psychopharmacologia 44 1975 53 59
24. M.J. Friedman Drug treatment for PTSDâ€"answers and questions Ann. N.Y. Acad. Sci. 821 1997 359 371
25. G. Griebel 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research Pharmacol. Ther. 65 1995 319 395
26. G. Griebel, R.J. Rodgers, G. Perrault, and D.J. Sanger Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test Pharmacol. Biochem. Behav. 57 1997 817 827
27. D.M. Jackson, C.E. Wallsten, E. Jerning, P.S. Hu, and A.M. Deveney Two selective 5-HT1A receptor antagonists, WAY-100 635 and NDL-249, stimulate locomotion in rats acclimatised to their environment and alter their behaviour: a behavioural analysis Psychopharmacology (Berl.) 139 1998 300 310
28. T. Jolas, R. Schreiber, A.M. Laporte, M. Chastanet, J. De Vry, T. Glaser, J. Adrien, and M. Hamon Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat? J. Pharmacol. Exp. Ther. 272 1995 920 929
29. J.R. Martin, T.M. Ballard, and G.A. Higgins Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety Pharm. Biochem. Behav. 71 2002 615 625
30. M.T. O'Connell, and G. Curzon A comparison of the effects of 8-OH-DPAT pretreatment on different behavioural responses to 8-OH-DPAT Eur. J. Pharmacol. 312 1996 137 143
31. S. Pollandt, C. Drephal, and D. Albrecht 8-OH-DPAT suppresses the induction of LTP in brain slices of the rat lateral amygdala NeuroReport 14 6 2003 895 897
32. L. Renyi, K.A. Moller, K. Ensler, and J. Evenden The non-competitive NMDA receptor antagonist (+)MK-801 counteracts the long-lasting attenuation of the hypothermic response induced by acute doses of 8-OH-DPAT in the rat Neuropharmacology 31 1992 1265 1268
33. R.J. Rodgers, and N.J.T. Johnson Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety Pharmacol. Biochem. Behav. 52 1995 297 303
34. A.Y. Shalev, S.P. Orr, T. Peri, S. Schreiber, and R.K. Pitman Physiologic responses to loud tones in Israeli patients with posttraumatic stress disorder Arch. Gen. Psychiatry 49 1992 870 875
35. D. Treit, J. Menard, and C. Royan Anxiogenic stimuli in the elevated plus-maze Pharmacol. Biochem. Behav. 44 1993 463 469
36. D. Treit, A. Degroot, S. Kashluba, and G.D. Bartoszyk Systemic EMD 68843 injections reduce anxiety in the shock-probe, but not the plus-maze test Eur. J. Pharmacol. 414 2â€"3 2001 245 248
37. B.A.T. VanderKolk The psychobiology and psychopharmacology of PTSD Hum Psychopharmacol. Clin. Exp. 16 2001 S49 S64